Basil Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 25 Year, 1 Month
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 0.60 M
- Revenue Growth 17.08%
- Profit Growth 26.12%
- Ebitda 8.22%
- Net Worth 8.93%
- Total Assets 22.16%
About Basil Biotech
Basil Biotech Private Limited (BBPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 December 1999 and has a history of 25 years and one month. Its registered office is in Champaran, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹0.60 M.
Gauri Bharati and Raju Bharti serve as directors at the Company.
Company Details
-
Location
Champaran, Bihar, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231BR1999PTC009084
-
Company No.
009084
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Dec 1999
-
Date of AGM
29 Sep 2016
-
Date of Balance Sheet
31 Mar 2016
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Basil Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gauri Bharati
|
Director | 30-Aug-2011 | Current |
|
Raju Bharti
|
Director | 30-Aug-2011 | Current |
Financial Performance of Basil Biotech.
Basil Biotech Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 17.08% increase. The company also saw a substantial improvement in profitability, with a 26.12% increase in profit. The company's net worth moved up by a moderate rise of 8.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Basil Biotech?
In 2016, Basil Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.60 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 May 2005 | Canara Bank | ₹0.60 M | Open |
How Many Employees Work at Basil Biotech?
Unlock and access historical data on people associated with Basil Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Basil Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Basil Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
